Addiction Institute at Mount Sinai

The Addiction Institute at Mount Sinai within the Behavioral Health System provides comprehensive and personalized care for patients with alcohol, substance, and behavioral (e.g., food and gambling) addictions.

View All Videos

Meet Our Team

Yasmin Hurd

Yasmin Hurd, PhD

Director, Addiction Institute at Mount Sinai
Timothy K Brennan

Timothy K Brennan, MD

Director of Addiction Services, AIMS - West/St. Luke's

Director of Addiction Services, AIMS - Beth Israel
Annie Levesque

Annie Levesque, MD

Medical Director, AIMS - West/St. Luke's
Don C Des Jarlais

Don C Des Jarlais, PhD

Director, Division of Epidemiology and Health Service Research, Mount Sinai Beth Israel
Uraina Clark

Uraina Clark, PhD

Assistant Professor, Neurology
Vilma Gabbay

Vilma Gabbay, MD

Chief, Pediatric Mood and Anxiety Disorders Program
Igor Galynker

Igor Galynker, MD

Director, Family Center for Bipolar Disorder, Mount Sinai Beth Israel
Rita Z Goldstein

Rita Z Goldstein, PhD

Chief, Neuropsychoimaging of Addiction and Related Conditions (NARC) Research
Thomas B Hildebrandt

Thomas B Hildebrandt, PsyD

Associate Professor of Psychiatry
Iliyan Ivanov

Iliyan Ivanov, MD

Medical Director, Comprehensive Adolescent Rehabilitation and Education services program, Mount Sinai West
Nelly Alia-Klein

Nelly Alia-Klein, PhD

Co-Chief, Neuropsychoimaging of Addiction and Related Conditions (NARC) Research Program
David Lehman

David Lehman, MD

ASSISTANT PROFESSOR
Andrew N Merling

Andrew N Merling, PhD

ASSISTANT CLINICAL PROFESSOR
ANNA M OPRESCU

ANNA M OPRESCU

Project Manager
David Perlman

David Perlman, MD

Associate Chief, Infectious Diseases, Mount Sinai Beth Israel
Joseph S Ruggiero

Joseph S Ruggiero, PhD

Associate Director, Addiction Treatment Services, Mount Sinai Beth Israel, Mount Sinai St. Luke’s, Mount Sinai West
Edwin Salsitz

Edwin Salsitz, MD

Medical Director, Division of Chemical Dependency, Mount Sinai Beth Israel
Shilpa R Taufique

Shilpa R Taufique, PhD

Director, CARES, Child and Family Institute; Director, Education and Training in Child and Adolescent Psychology
Anil A Thomas

Anil A Thomas, MD

Assistant Medical Director, Methadone Maintenance Treatment Program, Mount Sinai Beth Israel
Faye Chao

Faye Chao, MD

ASSISTANT PROFESSOR
Muhammad Parvaz

Muhammad Parvaz, PhD

ASSISTANT PROFESSOR
An-Li Wang

An-Li Wang, PhD

ASSISTANT PROFESSOR

Featured Labs

lab-ice-2.jpg Hurd Lab

Molecular Neuropsychopharmacology

lab-berin-2.jpg Goldstein & Alia-Kelin Lab

lab-research-4.jpg Nestler Lab

lab-clark-neuropsychology.jpg Clark Laboratory

lab-devi.jpg Devi Laboratory

Neuropeptides and their receptors, opiate receptor signal transduction, and narcotic addiction

lab-goate.jpg Goate Laboratory

lab-cellular-neurophysiology.jpg Han Laboratory

Cellular Neurophysiology

lab-kenny.jpg Kenny Laboratory

Behavioral and Molecular Neuroscience

lab-russo.jpg Russo Laboratory

lab-schaefer.jpg Schaefer Laboratory

lab-slesinger.jpg Slesinger Laboratory

lab-zachariou.jpg Zachariou Laboratory

Latest Publications

David C. Perlman and Ashly E. Jordan
Considerations for the Development of a Substance-Related Care and Prevention Continuum Model

Bagot RC, Cates HM, Purushothaman I, Lorsch ZS, Walker DM, Wang J, Huang X, Schlüter OM Maze I, Peña CJ, Heller EA, Issler O, Wang M, Song WM, Stein JL, Liu X, Doyle MA, Scobie KN, Sun HS, Neve RL, Geschwind D, Dong Y, Shen L, Zhang B, Nestler EJ.
Circuit-wide Transcriptional Profiling Reveals Brain Region-Specific Gene Networks Regulating Depression Susceptibility. Neuron. 2016 May 11. pii: S0896-6273(16)30074-5. doi: 10.1016/j.neuron.2016.04.015

Bassir Nia, A. et al.
Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis

Chen Z, Kenny PJ.
Running on Empty: Leptin Signaling in VTA Regulates Reward from Physical Activity. Cell Metabolism. 2015 Oct 6; 22(4):540-1.doi: 10.1016/j.cmet.2015.09.021

Clark US, Sweet LH, Morgello S, Philip NS, Cohen RA. (in press).
High early life stress and aberrant amygdala activity: Risk factors for elevated neuropsychiatric symptoms in HIV+ adults. Brain Imaging and Behavior

Friedman AK, Juarez B, Ku SM, Zhang H, Calizo RC, Walsh JJ, Chaudhury D, Zhang S, Hawkins A, Dietz DM, Murrough JW, Ribadeneira M, Wong EH, Neve RL, Han MH.
KCNQ channel openers reverse depressive symptoms via an active resilience mechanism

Golden SA, Heshmati M, Flanigan M, Christoffel DJ, Guise K, Pfau ML, Aleyasin H, Menard C, Zhang H, Hodes GE, Bregman D, Khibnik L, Tai J, Rebusi N, Krawitz B, Chaudhury D, Walsh JJ, Han MH, Shapiro ML, Russo SJ.
Basal forebrain projections to the lateral habenula modulate aggression reward. Nature. 2016 Jun 29;534(7609):688-92. doi: 10.1038/nature18601

View All Publications

Contact Us

Mount Sinai Addiction Treatment Services

Mount Sinai Beth Israel
Tel: 212-256-2623 

Mount Sinai St. Luke’s and Mount Sinai West
Tel: 212-523-6491

Mount Sinai Clinical Addiction Research

Tel: 212-824-9361
AIMS.Research@mssm.edu

Take Our Surveys

Addiction Institute at Mount Sinai Survey


Medical Marijuana Clinician Survey